Decreasing proline synthesis by reducing the level of pyrroline-5-carboxylate reductase 1 (PYCR1) in cancer-associated fibroblasts is sufficient to reduce tumor collagen production, tumor growth, and metastatic spread in vivo [133]. The gene discussed is PYCR1; the disease is neoplasm.